Accelerate Diagnostics CFO David Patience resigns effective June 30, 2025

Accelerate Diagnostics, Inc

David Patience notified Board on May 21, 2025; resignation effective June 30, 2025.
He served as principal financial and accounting officer; no replacement announced.
Resignation is for other professional opportunities, not due to any disagreement with the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Patience

Chief Financial Officer

Accelerate Diagnostics, Inc

Effective: 2025-06-30
Filed: May 28, 2025 23:59 UTC

On May 21, 2025, David Patience notified the Board of Directors of Accelerate Diagnostics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective June 30, 2025.

Source: SEC EDGAR

accession 0001104659-25-053564

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.